GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Polaris Group (TPE:6550) » Definitions » Net Margin %

Polaris Group (TPE:6550) Net Margin % : -2,328.31% (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Polaris Group Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Polaris Group's Net Income for the three months ended in Dec. 2024 was NT$-843.9 Mil. Polaris Group's Revenue for the three months ended in Dec. 2024 was NT$36.2 Mil. Therefore, Polaris Group's net margin for the quarter that ended in Dec. 2024 was -2,328.31%.

The historical rank and industry rank for Polaris Group's Net Margin % or its related term are showing as below:

TPE:6550' s Net Margin % Range Over the Past 10 Years
Min: -19948.26   Med: -7016.2   Max: -2338.92
Current: -2338.92


TPE:6550's Net Margin % is ranked worse than
82.65% of 997 companies
in the Biotechnology industry
Industry Median: -120.87 vs TPE:6550: -2338.92

Polaris Group Net Margin % Historical Data

The historical data trend for Polaris Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris Group Net Margin % Chart

Polaris Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7,016.20 -4,923.12 -17,866.64 -19,948.26 -2,338.92

Polaris Group Quarterly Data
Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10,326.27 -1,407.42 -1,716.87 -6,562.90 -2,328.31

Competitive Comparison of Polaris Group's Net Margin %

For the Biotechnology subindustry, Polaris Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polaris Group's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Polaris Group's Net Margin % falls into.


;
;

Polaris Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Polaris Group's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-2502.642/107
=-2,338.92 %

Polaris Group's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-843.919/36.246
=-2,328.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polaris Group  (TPE:6550) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Polaris Group Net Margin % Related Terms

Thank you for viewing the detailed overview of Polaris Group's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris Group Business Description

Traded in Other Exchanges
N/A
Address
NO.298, Ruiguang Road, 7th floor, Neihu District, Taipei, TWN
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.

Polaris Group Headlines

No Headlines